Condition
Small Vessel Disease
Total Trials
4
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Recruiting2
Unknown2
Clinical Trials (4)
Showing 4 of 4 trials
NCT06485128Not ApplicableUnknown
Investigating Multimodally Endothelial Dysfunction in Ocular and Systemic Disease
NCT05300997Recruiting
Translational Immunodiagnostics in Stroke (TrImS)
NCT06159140Not ApplicableRecruitingPrimary
Small Vessel Diseases: Ultra-realistic Microstructure Computational Model to Refine Individual Treatment
NCT03625830Not ApplicableUnknownPrimary
The Efficacy and Safety of SeQuent® Please in the Treatment of Small Vessel Disease (SVD) Patient
Showing all 4 trials